|

Prospective Asian Multicenter Prostate Cancer Focal Therapy Study (ProAMFocal)

RECRUITINGSponsored by Singapore General Hospital
Actively Recruiting
SponsorSingapore General Hospital
Started2023-05-06
Est. completion2028-05-06
Eligibility
Age40 Years – 85 Years
SexMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06491056

Summary

This is a multicenter observational study of patients undergoing focal therapy for prostate cancer in Asia

Eligibility

Age: 40 Years – 85 YearsSex: MALEHealthy volunteers accepted
Inclusion Criteria:

* Prostate Adenocarcinoma
* Maximum Gleason score 4+4
* Maximum cancer volume 1.5 ml (up to 2 lesions) or 3 ml (single lesion)
* Maximum Prostate Specific Antigen (PSA) level 15 ng/dl
* Maximum clinical stage T2c
* American Society of Anesthesiologist Criteria 2 or less

Exclusion Criteria:

* Extra-prostatic Extension on multi parametric magnetic resonance imaging (mpMRI); capsular contact is permitted

Conditions2

CancerProstate Cancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.